Sianny Herawati

Dr. Sianny Herawati

Clinical Pathology, Udayana University, Denpasar, Bali, Indonesia
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
SHSianny Herawati
Sianny Herawati
ISI Ketut Agus Somia
I Ketut Agus Somia
SKSully Kosasih
Sully Kosasih
IWI Nyoman Wande
I Nyoman Wande
JFJethro Felim
Jethro Felim
IPI Made Dwi Payana
I Made Dwi Payana
Sepsis is one of the major causes of morbidity and mortality in hospitals, especially in low- and middle-income countries, and represents a challenge to health care providers to carry out early detection, and accurate diagnosis and prognosis with cost-effective diagnostic tools. An observational prospective study was conducted from December 2021 to December 2022 to investigate the extended inflammatory parameters (EIPs) for sepsis management and analyze the survival of septic patients in the emergency unit, intensive care unit (ICU) and inpatient ward. Patients suspected of having sepsis underwent a sequential organ failure assessment (SOFA) evaluation and had blood drawn for complete blood counts (CBCs). Significant changes were observed in various CBC parameters and EIPs, and the sepsis group was followed up with for 30-day mortality. The study highlighted a significant difference yet strong discriminatory power to differentiate sepsis with an AUC of 0.924 against the non-sepsis group and an AUC of 0.991 against the healthy control group using combination of white blood cells and EIPs. Furthermore, the study showed good predictive ability for 30-day mortality with a hazard ratio of 2.311. In summary, this study provides evidence that the utilization of EIPs may be valuable in diagnosing and predicting patient outcomes, and thus will be beneficial for sepsis management in the hospital.

1 January 2022 in Bali Journal of Anesthesiology
Verified
Journal Article
Open access
PDF file
IPI Made Dharma Pramana
I Made Dharma Pramana
SHSianny Herawati
Sianny Herawati
CPCokorda Agung Wahyu Purnamasidhi
Cokorda Agung Wahyu Purnamasidhi
NMNi Kadek Mulyantari
Ni Kadek Mulyantari
ALA. A. Wiradewi Lestari
A. A. Wiradewi Lestari
IWI Nyoman Wande
I Nyoman Wande
Background: New biomarkers are urgently needed to predict the severity of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Eosinophil count and neutrophil-to-lymphocyte ratio (NLR) are new biomarkers for the severity of viral infection. Pentraxin 3 (PTX3) is a natural humoral immune mediator that can bind to viruses, complement, and apoptotic cells, and can trigger T-helper type 1 (Th1) to produce pro-inflammatory cytokines and their levels increase depending on the severity of the disease. Materials and Methods: This was a case-control study consisting of 66 patients infected with SARS-CoV-2 who were divided into critical patients (Group C) and noncritical patients (Group N). We obtained lab samples from the subjects upon admission. We then analyzed the data using the Mann–Whitney U test, receiving operator characteristic (ROC) analysis, and chi-square test with odds ratio (OR) to test the hypothesis. Results: Median eosinophil count, NLR, and PTX3 levels in Group C were 0 ×103/µL, 13.53 and 608.73 pg/mL, compared to 0.11 ×103/µL, 1.94 and 28.50 pg/mL in Group N. The ROC analysis showed good predictive ability for eosinophil count, NLR, and PTX3 with area under the curve (AUC) of 0.913, 0.988, and 0.942 to predict coronavirus disease-2019 (COVID-19) severity. At the cutoff eosinophil count of 0.035 × 103/µL, NLR 4.13 and PTX3 114.51 pg/mL, the OR values were 17.5, 320, and 72.5 (P < 0.05) with a sensitivity of 84.8%, 97.0%, and 90.9% and specificity 75.8%, 90.9%, and 87.9%. Conclusions: Eosinophil count, NLR, and PTX3 levels can be used as predictors of clinical severity in SARS-CoV-2. Eosinophil count of 4.13, and PTX3 level >114.51 pg/mL are risk factors for critical conditions for COVID-19.

16 May 2023 in Bali Medical Journal
Verified
Journal Article
Open access
PDF file
RSRosalyn Devina Santoso
Rosalyn Devina Santoso
AHAgus Roy Rusly Hariantana Hamid
Agus Roy Rusly Hariantana Hamid
TMTjokorda Gde Bagus Mahadewa
Tjokorda Gde Bagus Mahadewa
ISI Gusti Putu Hendra Sanjaya
I Gusti Putu Hendra Sanjaya
NBNi Nyoman Sri Budayanti
Ni Nyoman Sri Budayanti
SHSianny Herawati
Sianny Herawati
Link of Video https://youtu.be/8UIEdUv8za8 Introduction: Distal flap necrosis is one of the most common complications in flap procedure. Ascorbic acid (vitamin C) is one of the most widespread antioxidants available, while calcitriol, a metabolite of vitamin D, has anti-inflammatory and antioxidant properties. The purpose of this study was to determine the effect of ascorbic acid and calcitriol on the viability of Modified McFarlane random skin flaps in Wistar rats and its mechanism through suppression of proinflammatory cytokine Tumor Necrosis Factor-α (TNF-α). Methods: An experimental study used 28 Wistar rats, by creating a caudally based 3 cm x 9 cm Modified McFarlane random skin flap and divided into four groups. The first group was injected with 200 mg/kg/day ascorbic acid, the second group with 2μg/kg/day calcitriol, and the third group with 200 mg/kg/day ascorbic acid combined with 2μg/kg/day calcitriol was injected two hours after flap elevation for seven days, respectively. The control group was not given any intraperitoneal injection. After seven days, the percentage of flap viability rate was measured and tissue sampling was performed to measure the amount of capillary density and TNF-α in all groups. Results: The higher percentage of viable flap area was found in all treatment groups, the highest in the ascorbic acid group 80.63% (p<0.001). The highest capillary density was found in ascorbic acid combined with the calcitriol group (27/visual field, p<0.001) compared to all groups. It was also found that the amount of TNF-α in the tissue was lowest in the group administered by ascorbic acid combined with calcitriol compared to all groups 57.38 ng/L and 0.62 nmol/mL respectively compared to all groups (p<0.001). The higher percentage of viable flap area was correlated with a lower amount of TNF-α (p0.05). Conclusion: Ascorbic acid in combination with calcitriol improves the viability of Modified McFarlane random skin flaps by lowering TNF-α levels.

24 May 2021 in Bali Medical Journal
Verified
Journal Article
Open access
ENEkarini Katharina Yunarti Nabu
Ekarini Katharina Yunarti Nabu
NMNi Nyoman Mahartini
Ni Nyoman Mahartini
IWIda Ayu Putri Wirawati
Ida Ayu Putri Wirawati
SHSianny Herawati
Sianny Herawati
BPBetti Bettavia Hartama Pardosi
Betti Bettavia Hartama Pardosi
IPI Putu Yuda Prabawa
I Putu Yuda Prabawa
Background: Gaucher's disease is a rare Lysosomal Storage Disorder (LSD) caused by the accumulation of glucosylceramide/glucocerebroside. There are several types of Gaucher, such as non-neuronopathic, infantile-onset neuronopathic and juvenile-onset neuronopathic. This case study aims to evaluate Gaucher's disease in a 4-year-old child at Sanglah General Hospital, Bali, Indonesia. Case Presentation: A 4-years-old child is admitted to the hospital with a chief complaint of enlargement in the stomach. There is no pain in the bone as well as no sign of bleeding. The patient's parents are blood relatives. On physical examination, hepatosplenomegaly was found, a decreased level of hemoglobin and thrombocytes was also found in the hematology examination. There was an increase of level ferritin, Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), globulin, and triglycerides from chemistry evaluation, also decreasing level total cholesterol. From bone marrow aspiration was found an increase of activity of the megakaryocyte and Gaucher's cell. The result from enzyme examination found a decrease of activity enzyme ?-glucosidase. Suggestion to this patient is Enzyme Replacement Therapy (ERT). Conclusion: Gaucher's disease is a rare case and difficult to diagnose. A biochemistry examination using the enzyme -glucosidase is necessarily needed as well as a suggestion of ERT.

10 November 2022 in International journal of health sciences
Verified
Journal Article
Open access
PDF file
IPI Gusti Ayu Putri Purwanthi
I Gusti Ayu Putri Purwanthi
AHAgus Roy Rusly Hariantana Hamid
Agus Roy Rusly Hariantana Hamid
TMTjokorda Gde Bagus Mahadewa
Tjokorda Gde Bagus Mahadewa
IAI Made Suka Adnyana
I Made Suka Adnyana
ISI Gusti Putu Hendra Sanjaya
I Gusti Putu Hendra Sanjaya
GSGede Wara Samsarga
Gede Wara Samsarga
Local hyperadrenergic states after a random flap elevation mediated by humoral vasoconstrictors can lead to flap necrosis. This study aimed to evaluate the effect of Botulinum Toxin A (BoNT-A) on reducing levels of Norepinephrine (NE) as the main humoral vasoactive substance, as well as its additive effect with Vascular Endothelial Growth Factor (VEGF) in increasing the viability of random flap. 28 Wistar Rats with Caudally Based Modified McFarlane Flap were divided into four groups. Group I received BoNT-A 3 days before flap elevation, group II received VEGF immediately after flap elevation, group III received a combination of BoNT-A and VEGF, group IV was a control group. Result in this study NE levels lowest was found in the BoNT-A+VEGF combination group (94.63 ± 5 .25 ng/ml, p<0.05 in group I, p<0.01 in groups II and IV). The highest value of FVR was shown in the BoNT-A+VEGF combination group (93.37 ± 2.19 %, p < 0.05 in group I, p < 0.01 in groups II and IV). Meanwhile, the increase in flap viability in the VEGF group was not statistically significant. So Conclusion administration of BoNT-A in combination with VEGF can increase the viability of random flaps by decreasing NE levels.

1 June 2021 in Intisari Sains Medis
Verified
Journal Article
Open access
NSNi Ketut Puspa Sari
Ni Ketut Puspa Sari
NMNi Nyoman Mahartini
Ni Nyoman Mahartini
NMNi Kadek Mulyantari
Ni Kadek Mulyantari
APAnak Agung Ayu Lydia Prawita
Anak Agung Ayu Lydia Prawita
NKNi Komang Krisnawati
Ni Komang Krisnawati
ENEkarini Katharina Yunarti Nabu
Ekarini Katharina Yunarti Nabu
Background: CD5 is expressed in several B-lymphocyte malignancies, including Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL), but CD5 positive B-cell lineage Acute Lymphoblastic Leukemia (ALL) is extremely rare. Aberrant T-cell antigen expression is associated with poor prognosis and is a useful marker to identify patients at increased risk. This case report aims to elaborate on the aberrant expression of CD5 in B-lineage ALL. Case Presentation: A 16-years-old male presented with a history of gum bleeding and abdominal pain of 7 days with associated fever, weakness and bone pain of 2-month duration. The bone marrow aspiration showed lymphoblast 30 % with the positive vacuole. In addition, the immunophenotyping test indicates for leukemia B-lineage with expression CD19, CD10, HLA-DR, CD 34, and there is the aberrant expression of CD5. Conclusion: Aberrant expression CD5 in cases of ALL B lineage is very rare. This can be associated with a poor prognosis.